HAEMONETICS CORP 4
4 · HAEMONETICS CORP · Filed Nov 5, 2007
Insider Transaction Report
Form 4
Popovsky Mark A
VP, Corporate Medical Director
Transactions
- Purchase
Common Stock
2007-11-01$40.66/sh+253$10,288→ 4,645 total
Holdings
- 11,230
Non-Qualified Stock Option (right to buy)
Exercise: $33.15From: 2002-04-30Exp: 2011-04-30→ Common Stock (11,230 underlying) - 13,451
Non-Qualified Stock Option (right to buy)
Exercise: $51.07From: 2008-10-24Exp: 2014-10-24→ Common Stock (13,451 underlying) - 15,000
Non-Qualified Stock Option (right to buy)
Exercise: $31.66From: 2003-04-29Exp: 2012-04-29→ Common Stock (15,000 underlying) - 10,000
Non-Qualified Stock Option (right to buy)
Exercise: $26.11From: 2005-05-05Exp: 2014-05-05→ Common Stock (10,000 underlying) - 17,000
Non-Qualified Stock Option (right to buy)
Exercise: $41.15From: 2006-07-27Exp: 2015-07-27→ Common Stock (17,000 underlying) - 14,891
Non-Qualified Stock Option (right to buy)
Exercise: $52.76From: 2007-05-05Exp: 2013-05-05→ Common Stock (14,891 underlying)
Footnotes (3)
- [F1]Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.
- [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grants was made under 2005 Long Term Incentive Compensation Plan.
- [F3]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.